PolyPid Announces Dikla Czaczkes Akselbrad Assumes Role of CEO

Work in a lab
July 2022

Company Previously Announced Planned CEO Transition Following Retirement of Amir Weisberg PETACH TIKVA, Israel , July 05, 2022 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD ) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, announced today that

Contact Us

    Your information will be processed in accordance with the Privacy Policy.

    Contact icon